Pharmacological strategies for smoking cessation in patients with chronic obstructive pulmonary disease: a pragmatic review
- 29 December 2020
- journal article
- other
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 22 (7) , 835-847
Abstract
Introduction: Chronic obstructive pulmonary disease (COPD) is progressive inflammatory disease of the lungs in which smoking plays a significant pathogenic role. Smoking cessation is the only therapeutic intervention which was demonstrated to interfere with disease progression. Smoking cessation intervention can benefit from pharmacological therapies such as nicotine replacement therapies, bupropion, or varenicline which can be given individually or in combination, their effectiveness being demonstrated in various clinical trials enrolling COPD patients. Areas covered: The authors provide a pragmatic discussion of the clinical data of the main studies evaluating therapies for smoking cessation within COPD starting with the seminal Lung Health Study and continuing with more recent ones. Expert opinion: Smoking cessation is one of the most difficult therapeutic interventions in COPD, despite having the highest impact on disease progression and despite the demonstrated benefit of the discussed pharmacological therapies. Potential approaches to maximize its chance of success might be represented by prolonging the time of administration, combinational options, or sequential pharmacotherapy.Keywords
Funding Information
- not funded
This publication has 52 references indexed in Scilit:
- General practice counseling for patients with chronic obstructive pulmonary disease to quit smoking: Impact after 1year of two complex interventionsPatient Education and Counseling, 2011
- Comparison of Available Treatments for Tobacco AddictionCurrent Psychiatry Reports, 2010
- Smoking outcome by psychiatric history after behavioral and varenicline treatmentJournal of Substance Abuse Treatment, 2010
- Smoking cessation interventions in COPD: a network meta-analysis of randomised trialsEuropean Respiratory Journal, 2009
- Efficacy of confronting smokers with airflow limitation for smoking cessationEuropean Respiratory Journal, 2009
- Nurse-Conducted Smoking Cessation in Patients With COPD Using Nicotine Sublingual Tablets and Behavioral SupportChest, 2006
- Are patients with COPD psychologically distressed?European Respiratory Journal, 2005
- Characteristics of Participants Who Stop Smoking and Sustain Abstinence for 1 and 5 Years in the Lung Health StudyPreventive Medicine, 2000
- The US Lung Health StudyRespirology, 1997
- Control of behavior by intravenous nicotine injections in human subjectsPharmacology Biochemistry and Behavior, 1983